DSPE-PEG5000 ,MPEG5000-DSPE,384835-61-4
作者:DSPE-PEG5000 ,MPEG5000-DSPE,384835-61-4 发布时间:2022-08-01 09:05:19
次浏览
DSPE-PEG5000 ,MPEG5000-DSPE,384835-61-4
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene
glycol)5000]
Synonym: Methoxy
Polyethylene Glycol DSPE5000, MethoxyPEG5000 DSPE, mPEG5000 DSPE, PEG5000
DSPE, DSPE-MPEG5000.
Product
Structure:
Product
Specifications:
l Catalog
Numbers:PS1-DE-5K.
l Appearance: White
to off-white solid.
l Solubility: >10
mg/mL in warm water, chloroform, DCM, methanol.
l Stability: 2 Years at-20°C, Desiccate.
l CAS
Number: 384835-61-4.
l Molecular
Weight:5801.071 (average MW due to polydispersity of
PEG).
l Purity: >95%.
Description:
1,2-Distearoyl-sn-Glycero-3-Phosphoethanolamine
with conjugated methoxyl poly(ethylene glycol) (DSPE-mPEG) is a
linear phospholipid PEG conjugate which has both hydrophilicity and hydrophobility.
Pegylated phospholipids are excellent liposome or micelle formation materials
that can be used for drug delivery. Pegylation of phospholipids significantly
improves the blood circulation time and stability for encapsulated drugs. These
materials can also be used for targeted drug delivery by modifying their
surfaces with targeting ligands such as antibodies, peptides.
Handling
and Use:
DSPE
PEG5000(MPEG5000-DSPE) should always be kept in low temperature in
dry condition. Prepare fresh solution right before use.Avoid frequent thaw and
freezing. For more information about using this product, .
Related
Products:
DSPE-PEG-NH2,
DSPE-PEG-COOH
DSPE-PEG-NHS
,DSPE-PEG-FA
DSPE-PEG-SH,DSPE-PEG-MAL
References:
l Ultrafast
and Non-invasive Long-Term Bioimaging with Highly Stable Red
Aggregation-Induced Emission Nanoparticles------ Analytical
Chemistry(IF=6.042)
l Ultra-small
nanocluster mediated synthesis of Nd 3+ -doped core-shell
nanocrystals with emission in the second near-infrared window for multimodal
imaging of tumor vasculature------ Biomaterials(IF=10.273)
l Novel
small molecular dye-loaded lipid nanoparticles with efficient near-infrared-II
absorption for photoacoustic imaging and photothermal therapy of hepatocellular
carcinoma------ Biomaterials(IF=10.273)
l Hybrid
Nanoclusters for Near-Infrared to Near-Infrared Upconverted Persistent
Luminescence Bioimaging------ Acs applied materials&interfaces(IF=8.097)
l Hierarchically
Theranostic Nanomedicine: MRI Contrast Agents as the Physical Vehicle Anchor
for High Drug Loading and Triggered on-demand Delivery------ Journal
of Materials Chemistry B(IF=4.776)
l Dual
Near-Infrared Emissive Luminescent Nanoprobe for Ratiometric Luminescent
Monitoring of ClO-in Living Organisms------ Acs applied materials&interfaces(IF=8.097)
l Near-Infrared
Upconversion Luminescence and Bioimaging In Vivo Based on Quantum Dots------ Advanced
science(IF=12.441)
l Afatinib-loaded
Immunoliposomes Functionalized with Cetuximab: a Novel Strategy Targeting the
Epidermal Growth Factor Receptor for Treatment of Non-small-cell Lung Cancer------ International
Journal of Pharmaceutics(IF=3.862)
l Zinc
phthalocyanine-soybean phospholipid complex based drug carrier for switchable
photoacoustic/fluorescence image, multiphase photothermal/photodynamic
treatment and synergetic therapy------Journal of Controlled Release(IF=7.877)
l Mitoxantrone-preloaded
water-responsive phospholipid-amorphous calcium carbonate hybrid nanoparticles
for targeted and effective cancer therapy------ International
Journal of Nanomedicine(IF=4.37)
l Ultralong Circulating
Choline Phosphate Liposomal Nanomedicines
for Cascaded Chemo-Radiotherapy------ Biomaterials
Science(IF=5.831)
l Nano-biotinylated
liposome-based immunoassay for the ultrasensitive detection of protein
biomarker in urine------ Talanta(IF=4.244)
l In vitro
and in vivo evaluation of folate mediated PEGylated nanostructured lipid
carriers for the efficient delivery of furanodiene.
l Multifunctional
Nanoparticles Enable Efficient Oral Delivery of Biomacromolecules via Improving
Payload Stability and Regulating the Transcytosis Pathway------Acs applied materials&interfaces(IF=8.097)
l Light/magnetic
hyperthermia triggered drug released from multi-functional thermo-sensitive
magnetoliposomes for precise cancer synergetic theranostics------Journal of
Controlled Release(IF=7.877)
l Novel
theranostic zinc phthalocyanine–phospholipid complex self-assembled nanoparticles
for imaging-guided targeted photodynamic treatment with
controllable ROS production and shape-assisted enhanced cellular uptake------ Colloids
and Surfaces B: Biointerfaces(IF=3.997)
l Erythrocyte
membrane camouflaged graphene oxide for tumor-targeted
photothermal-chemotherapy------ Carbon(IF=7.082)
This
product is for research use only and is not intended for use in humans or for
diagnostic use.